Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells-Reference-Cited by-同舟云学术

Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells

Published:1999-06 Issue:6 Volume:133 Page:566-574
ISSN:0022-2143
Container-title:Journal of Laboratory and Clinical Medicine
language:en
Short-container-title:Journal of Laboratory and Clinical Medicine

Author:

Kawakami Atsushi,Tsuboi Masahiko,Urayama Satoshi,Matsuoka Naoki,Yamasaki Satoshi,Hida Ayumi,Aoyagi Takahiko,Furuichi Itaru,Nakashima Tomoki,Migita Kiyoshi,Kawabe Yojiro,Nakashima Munetoshi,Origuchi Tomoki,Eguchi Katsumi

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference35 articles.

1. Rheumatoid arthritis: pathophysiology and implications for therapy;Harris;N Engl J Med,1990

2. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment;Hale;Arthritis Rheum,1989

3. Augmented interleukin 1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction;Miyasaka;Arthritis Rheum,1988

4. Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis;Nakao;J Rheumatol,1990

5. T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites;Reme;Arthritis Rheum,1990

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study;Modern Rheumatology;2022-08-13

2. Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching;Modern Rheumatology;2022-06-13

3. Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis;Clinical Rheumatology;2021-04-29

4. The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission;Modern Rheumatology;2021-03-16

5. Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis;Zeitschrift für Rheumatologie;2020-12-21